Lion Corporation (LIOPF)
| Market Cap | 3.71B +32.7% |
| Revenue (ttm) | 2.82B +6.2% |
| Net Income | 157.50M -15.7% |
| EPS | 0.57 -15.7% |
| Shares Out | n/a |
| PE Ratio | 20.34 |
| Forward PE | n/a |
| Dividend | 0.21 (1.85%) |
| Ex-Dividend Date | Dec 29, 2026 |
| Volume | 4,000 |
| Open | 11.51 |
| Previous Close | 10.50 |
| Day's Range | 11.51 - 11.51 |
| 52-Week Range | 10.00 - 11.51 |
| Beta | -0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
About Lion Corporation
Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through Consumer Goods, Industrial Products, and Overseas segments. The company provides oral healthcare products, including toothpastes, toothbrushes and cleaning tools, dental rinses and mouthwashes, periodontitis ointments, and denture products; beauty care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, hygiene care, body washes, acne care, antiperspirants and deodorants, men’s care, and foot and... [Read more]
Financial Performance
In 2025, Lion Corporation's revenue was 422.09 billion, an increase of 2.22% compared to the previous year's 412.94 billion. Earnings were 27.59 billion, an increase of 30.15%.
Financial numbers in JPY Financial StatementsNews
Lion Corporation Quarterly report: Q3 2026
Lion Corporation has published its Q3 2026 quarterly earnings report on November 6, 2026.
Lion Corporation Slides: Q3 2026
Lion Corporation has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 6, 2026.
Lion Corporation Earnings Call Transcript: Q2 2026
Sales and profit exceeded expectations in Q2 FY2026, driven by strong Oral Healthcare growth in Japan and recovery in overseas markets. Despite a significant increase in raw material costs, management remains confident in achieving full-year targets through price hikes and cost controls.
Lion Corporation Quarterly report: Q2 2026
Lion Corporation has published its Q2 2026 quarterly earnings report on August 7, 2026.
Lion Corporation Slides: Q2 2026
Lion Corporation has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Lion Corporation Transcript: Investor update
Strong market positions in Asia are being leveraged through a glocalization strategy, prioritizing high value-added oral healthcare and expanding into beauty care and pharmaceuticals. Organizational restructuring and local leadership drive rapid, profitable growth and adaptation to evolving consumer needs.
Lion Corporation Earnings Call Transcript: Q1 2026
Q1 saw solid sales and profit growth, led by oral healthcare and overseas integration, with margins improving. Despite JPY 3-4 billion in expected cost increases from Middle East risks, full-year targets and dividend guidance remain unchanged, supported by proactive countermeasures.
Lion Corporation Slides: Q1 2026
Lion Corporation has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 12, 2026.
Lion Corporation Quarterly report: Q1 2026
Lion Corporation has published its Q1 2026 quarterly earnings report on May 12, 2026.
Lion Corporation Earnings Call Transcript: Q4 2025
Revenue and profit exceeded guidance for FY 2025, driven by high value-added products and overseas growth. FY 2026 targets further margin expansion, with strong capital allocation to oral healthcare and continued dividend increases.
Lion Corporation Slides: Q4 2025
Lion Corporation has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 12, 2026.
Lion Corporation Quarterly report: Q4 2025
Lion Corporation has published its Q4 2025 quarterly earnings report on February 12, 2026.